Extracellular Microparticles Encapsulated with Diallyl Trisulfide Interfere with the Inflammatory Tumor

Yuping Liu1,2, Rongping Fu1,2, Shumei Tu1,2

  • 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China.

Molecular Pharmaceutics
|February 15, 2021
PubMed

Insights

Diallyl trisulfide microparticles (DATS-MPs) effectively target lung metastasis by interfering with the tumor microenvironment. These DATS-MPs show enhanced antimetastatic effects compared to DATS alone in mouse models.

Area of Science:

  • Oncology
  • Nanomedicine
  • Pharmacology

Background:

  • Lung metastasis is a critical factor in the late-stage progression of many solid tumors.
  • Diallyl trisulfide (DATS), derived from garlic, exhibits significant antimetastatic properties.
  • Limited biocompatible carriers hinder the clinical application of DATS for metastasis treatment.

Purpose of the Study:

  • To develop and evaluate extracellular microparticles loaded with DATS (DATS-MPs) for enhanced antimetastatic therapy.
  • To investigate the targeting and therapeutic efficacy of DATS-MPs in lung metastasis models.
  • To elucidate the mechanism by which DATS-MPs modulate the prometastatic inflammatory microenvironment.

Main Methods:

  • Preparation and characterization of DATS-loaded microparticles (DATS-MPs) derived from B16BL6 extracellular vesicles.
  • In vitro assessment of DATS-MP interaction with cancer cells and lung epithelial cells.
  • In vivo evaluation of DATS-MP biodistribution and antimetastatic efficacy in spontaneous and experimental metastasis mouse models.
  • Analysis of molecular markers associated with inflammation and metastasis in lung tissues.

Main Results:

  • DATS-MPs were successfully prepared and demonstrated characteristics of extracellular vesicles.
  • DATS-MPs showed preferential fusion with cancer cells and lung epithelial cells in vitro.
  • Systemically administered DATS-MPs accumulated in lung tissue, the primary site of metastasis.
  • DATS-MPs significantly enhanced antimetastatic effects compared to DATS alone in mouse models (p < 0.05).
  • DATS-MPs inhibited tumor cell migration and reduced inflammatory markers (S100A8/A9, SAA, IL-6) and key signaling molecules (fibronectin, MRP8, MPO, TLR4-Myd88) in lung tissue.

Conclusions:

  • DATS-MPs represent a promising drug delivery system for enhancing the antimetastatic efficacy of DATS.
  • DATS-MPs effectively target lung tissue and modulate the prometastatic inflammatory microenvironment.
  • The developed DATS-MP system holds potential for improving therapeutic outcomes in metastatic cancer treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K